|
Market Closed -
Nasdaq
21:00:00 06/10/2025 BST
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 07/10/25 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 07/10/25 | MannKind Completes Acquisition of scPharmaceuticals | MT |
| Market Cap | 305M 261M 244M 223M 420M 29.17B 428M 2.89B 1.13B 14.62B 1.14B 1.12B 48.39B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 281M 240M 224M 206M 387M 26.87B 394M 2.66B 1.04B 13.47B 1.05B 1.03B 44.59B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.42% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: scPharmaceuticals Inc.
| 1 year | 4.58 |  | 5.7 |
| 3 years | 1.94 | | 8.05 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 06/10/2025 |
| Director of Finance/CFO | 50 | 06/10/2025 | |
David Thomson
SEC | Corporate Secretary | 59 | 06/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 06/10/2025 |
David Thomson
BRD | Director/Board Member | 59 | 06/10/2025 |
| Director/Board Member | 50 | 06/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/10/25 | Issuer sale | Director | 72,174 | 0.1442% | ||
| 07/10/25 | Issuer sale | Director | 84,422 | 0.1687% | ||
| 07/10/25 | Issuer sale | Director | 49,750 | 0.0994% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +27.42% | -25.49% | 305M | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,141B | |
| -2.21% | +2.02% | +49.50% | +55.01% | 659B | |
| -1.56% | +4.39% | +25.19% | +74.39% | 470B | |
| +1.20% | +2.62% | +41.69% | +45.78% | 366B | |
| -0.61% | +2.10% | +23.43% | +41.34% | 302B | |
| +0.32% | +3.25% | +0.94% | +13.42% | 254B | |
| -1.95% | +3.80% | +46.31% | +65.66% | 239B | |
| -1.10% | -0.70% | -14.31% | -52.66% | 207B | |
| -2.82% | +3.84% | +20.81% | +89.04% | 183B | |
| Average | -1.15% | +2.59% | +29.74% | +43.42% | 382.13B | |
| Weighted average by Cap. | -1.64% | +3.12% | +43.48% | +70.85% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCPH Stock
Select your edition
All financial news and data tailored to specific country editions
